Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$695,767
+$248,287 QoQ
Shares Held
13,278
+4.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#229
of 421 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
This page
|
13,278 | $695,767 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $695,767 | 13,278 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $447,480 | 12,655 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $361,781 | 12,930 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $390,630 | 13,021 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $410,639 | 14,353 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $647,885 | 19,621 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $115,931 | 4,031 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $106,529 | 3,806 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $75,481 | 3,132 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $73,197 | 2,704 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,961 | 287 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,677 | 167 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,945 | 158 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,454 | 158 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,128 | 158 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,528 | 158 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,706 | 158 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,262 | 162 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,768 | 162 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,643 | 183 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,119 | 168 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,951 | 158 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,152 | 158 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $20,476 | 1,420 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||